According to Dan Stanton of Outsourcing-Pharma, CROs who focus on the patient will have the competitive advantage. At the Partnerships in Clinical Trials (PCT) conference in Hamburg, Germany, representatives from AstraZeneca, EMD and Bayer discuss how having a patient centric vision could improve patient recruitment and accelerate the pace of clinical trials.
For a link to this article, please click here. Pearl IRB is obsessed with expediting life science product development regulatory pathways. How can we help you? Please contact us.